Easy Read Information
Inflammatory Bowel Disease (IBD) is a group of diseases of the bowl and colon.
This page tells you about the team who specialise in these diseases.
The IBD team includes seven consultants, one specialist nurse, two research nurses and four middle grades doctors (specialist registrars). The IBD team is well supported by three radiologists who have a special interest in bowel imaging.
What we do
We are in the process of reorganising our existing clinics in to two large joint clinics predominantly dedicated to the care of patients with IBD. There are many advantages to a joint clinic such as access to a dietitian, specialist nurse and a higher likelihood of being assessed by a consultant with a special interest in IBD.
The joint ‘IBD clinics’ will consist of three or four medical consultants, a specialist nurse, a research nurse and two special registrars. We also have access to a specialist dietitian in the clinic to provide support to patients where necessary. We accept referrals from primary, secondary and tertiary care. There are also two nurse led clinics, which include clinics for monitoring of bloods for immuno-suppressant treatment and for those with stable IBD. In addition, the IBD specialist nurse provides telephonic support for patients who need urgent advice.
Gastroenterology Unit (Endoscopy)
Opposite ‘L’, ‘M’ & ‘N’ Clinics,
0151 706 2726
Professor Jonathan Rhodes
Dr Paul Collins
Locum Consultant Gastroenterologist
Dr Anthony Ellis
Professor Chris Probert
Dr Melita Gordon
Dr Neil Haslam
0151 706 3558
Dr Sreedhar Subramanian
The department has a long standing interest in clinical trial, particularly in new therapies for inflammatory bowel disease.
We are involved in several clinical trials of new therapies for IBD at present. Some of these are local trials whilst others are multi-centre multinational trials. We have a dedicated, experienced research nurse, Kate Martin, who is involved in co-ordinating trials and reviewing trial patients. We have also recently appointed an additional research nurse, Andrew Kneebone. Some of the current clinical trials include:
Triple antibiotics vs budesonide in active Crohn’s disease - A local trial for people with active Crohn’s disease. The aim of the trial is to work out how a 3 antibiotic treatment compares with standard steroid treatment. Participants will be randomly assigned either A) 3 antibiotics (ciprofloxacin,trimethoprim and metronidazole for 10 weeks or B) budesonide (a standard steroid therapy for Crohn’s disease) for 12 weeks.
Plantain to prevent relapse of Crohn’s disease - A trial for people with current inactive Crohn’s disease (but flared up at sometime in the previous year). The aim is to evaluate whether plantain fibre reduces the flare up rate in Crohn’s disease. Participants are randomly assigned to plantain fibre (banana fibre) or placebo for one year.
Laquinomod in active Crohn’s disease - Part of a multicentre study for patients with active Crohn’s disease to evaluate whether a new drug laquinomod reduces the activity of Crohn’s disease.
TOPPIC trial - A multi-centre trial to examine whether mercaptopurine (an immunosuppressive drug) reduces the recurrence of Crohn’s disease after sugery. Participant are randomised to mercaptopurine or placebo and are assessed by endoscopy and by symptoms recurrence.
Adalimumab registry - A long-term safety follow up trial of people with Crohn’s disease who are receiving adalimumab.
CONSTRUCT - A nationwide trial to examine which of two immunosuppressive drugs (ciclosporin or infliximab) is better in treating people with very active ulcerative colitis.
Cycol - A multicentre trial to examine the efficacy of a novel formulation of ciclosporin for the management of ulcerative colitis.
There are several further trials in development. You could discuss your suitability for participation in trials during your clinic appointment or contact one of the research nurses.